MDL 28170 attenuates gentamicin ototoxicity

Audiological Medicine

Volumn 3, Issue 2, 2005, Pages 82-89

  Lanzoni, Irene ^a   Corbacella, Elisa ^a   Ding, Dalian ^b   Previati, Maurizio ^a   Salvi, Richard ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Apoptosis; Gentamicin; Hair cell; MDL 28170; Ototoxicity

Indexed keywords

[1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CALPAIN; CASPASE; GENTAMICIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL DAMAGE; CELL DESTRUCTION; CELL LOSS; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; EAR PROTECTION; HAIR CELL; INNER EAR; NEPHROTOXICITY; NERVE DEGENERATION; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT; STEREOCILIUM;

EID: 22344454923     PISSN: 1651386X     EISSN: None     Source Type: Journal    
DOI: 10.1080/16513860510033800     Document Type: Article

References (54)

1. Forge A, Schacht J. Aminoglycoside antibiotics. Audiol Neurootol 2000; 5: 3-22.
2. Mulherin D, Fahy J, Grant W, Keogan M, Kavanagh B, FitzGerald M. Aminoglycoside induced ototoxicity in patients with cystic fibrosis. Ir J Med Sci 1991; 160: 173-5.
3. Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 1999; 104: 375-81.
4. Howard MT, Anderson CB, Fass U, Khatri S, Gesteland RF, Atkins JF, Flanigan KM. Readthrough of dystrophin stop codon mutations induced by aminoglycosides. Ann Neurol 2004; 55: 422-6.
5. Kerem E. Pharmacological therapy for stop mutations: how much CFTR activity is enough? Curr Opin Pulm Med 2004; 10: 547-52.
6. Ding D, Stracher A, Salvi RJ. Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear Res 2002; 164: 115-26.
7. Sha S, Taylor R, Forge A, Schacht J. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 2001; 155: 1-8.
8. Clerici WJ, Hensley K, DiMartino DL, Butterfield DA. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 1996; 98: 116-24.
9. Hirose K, Westrum LE, Stone JS, Zirpel L, Rubel EW. Dynamic studies of ototoxicity in mature avian auditory epithelium. Ann N Y Acad Sci 1999; 884: 389-409.
10. Takumida M, Popa R, Anniko M. Free radicals in the guinea pig inner ear following gentamicin exposure. ORL J Otorhinolaryngol Relat Spec 1999; 61: 63-70.
11. Clerici WJ, Yang L. Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hear Res 1996; 101: 14-22.
12. Sha SH, Schacht J. Salicylate attenuates gentamicin-induced ototoxicity. Lab Invest 1999; 79: 807-13.
13. McFadden SL, Ding D, Salvemini D, Salvi RJ. M40403, a superoxide dismutase mimetic, protects cochlear hair cells from gentamicin, but not cisplatin toxicity. Toxicol Appl Pharmacol 2003; 186: 46-54.
14. Forge A. Outer hair cell loss and supporting cell expansion following chronic gentamicin treatment. Hear Res 1985; 19: 171-82.
15. Nakagawa T, Yamane H, Takayama M, Sunami K, Nakai Y. Apoptosis of guinea pig cochlear hair cells following chronic aminoglycoside treatment. Eur Arch Otorhinolaryngol 1998; 255: 127-31.
16. Cheng AG, Cunningham LL, Rubel EW. Hair cell death in the avian basilar papilla: characterization of the in vitro model and caspase activation. J Assoc Res Otolaryngol 2003; 4: 91-105.
17. Bartus RT, Elliott PJ, Hayward NJ, Dean RL, Harbeson S, Straub JA, et al. Calpain as a novel target for treating acute neurodegenerative disorders. Neurol Res 1995; 17: 249-58.
18. Nath R, Raser KJ, McGinnis K, Nadimpalli R, Stafford D, Wang KK. Effects of ICE-like protease and calpain inhibitors on neuronal apoptosis. Neuroreport 1996; 8: 249-55.
19. Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem J 1997; 328: 721-32.
20. Saito K, Elce JS, Hamos JE, Nixon RA. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer's disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 1993; 90: 2628-32.
21. Richard I, Brenguier L, Dincer P, Roudaut C, Bady B, Burgunder JM, et al. Multiple independent molecular aetiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet 1997; 60: 1128-38.
22. Stracher A. Calpain inhibitors as neuroprotective agents in neurodegenerative disorders. Intern Tinnitus J 1997; 3: 71-5.
23. Bartus RT, Elliott PJ, Hayward NJ, Dean RL, Harbeson S, Straub JA, et al. Calpain as a novel target for treating acute neurodegenerative disorders. Neurol Res 1995a; 17: 249-58.
24. Badalamente MA, Hurst LC, Stracher A. Neuromuscular recovery after peripheral nerve repair: effects of an orally-administered peptide in a primate model. J Reconstr Microsurg 1995; 11: 429-37.
25. Bartus RT, Elliott PJ, Hayward NJ, Dean RL, Harbeson S, Straub JA, et al. Calpain as a novel target for treating acute neurodegenerative disorders. Neurological Res 1995b; 17: 249-58.
26. Saatman KE, Murai H, Bartus RT, Smith DH, Hayward NJ, Perri BR, McIntosh TK. Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc Nat Acad Sci USA 1996; 93: 3428-33.
27. Wang KKW, Nath R, Raser KJ, Hajimohammadreza I. Maitotoxin induces calpain activation in SH-SY5Y neuroblastoma cells and cerebrocortical cultures. Arch Biochem Biophys 1996; 331: 208-14.
28. Jordan J, Galindo MF, Miller RJ. Role of calpain- and interleukin-1 beta converting enzyme-like proteases in the beta-amyloid-induced death of rat hippocampal neurons in culture. J Neurochem 1997; 68: 1612-21.
29. Cheng AG, Huang T, Stracher A, Kim A, Liu W, Malgrange B, et al. Calpain inhibitors protect auditory sensory cells from hypoxia and neurotrophin- withdrawal induced apoptosis. Brain Res 1999; 850: 234-43.
30. Wang J, Ding D, Shulman A, Stracher A, Salvi RJ. Leupeptin protects sensory hair cells from acoustic trauma. Neuroreport 1999; 10: 811-6.
31. 2+ caused by streptomycin in the isolated cochlear OHC. Chung Hua Erh Pi Yen Hou Ko Tsa Chih 1995; 30: 227-9.
32. Shimizu A, Takumida M, Anniko M, Suzuki M. Calpain and caspase inhibitors protect vestibular sensory cells from gentamicin ototoxicity. Acta Otolaryngol 2003; 123: 459-65.
33. Aoyagi T, Takeuchi T, Matsuzaki A, Kawamura K, Kondo S. Leupeptins, new protease inhibitors from Actinomycetes. J Antibiot (Tokyo) 1969; 22: 283-6.
34. Takumida M, Anniko M, Shimizu A, Watanabe H. Neuroprotection of vestibular sensory cells from gentamicin ototoxicity obtained using nitric oxide synthase inhibitors, reactive oxygen species scavengers, brain-derived neurotrophic factors and calpain inhibitors. Acta Otolaryngol 2003; 123: 8-13.
35. Kwak KB, Kambayashi J, Kang MS, Ha DB, Chung CH. Cell-penetrating inhibitors of calpain block both membrane fusion and filamin cleavage in chick embryonic myoblasts. FEBS Lett 1993; 323: 151-4.
36. Osanai T, Nagai Y. Suppression of experimental allergic encephalomyelitis (EAE) with liposome-encapsulated protease inhibitor: therapy through the blood-brain barrier. Neurochem Res 1984; 9: 1407-16.
37. Li PA, Howlett W, He QP, Miyashita H, Siddiqui M, Shuaib A. Postischaemic treatment with calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischaemia. Neurosci Lett 1998; 247: 17-20.
38. Buki A, Farkas O, Doczi T, Povlishock JT. Preinjury administration of the calpain inhibitor MDL 28170 attenuates traumatically induced axonal injury. J Neurotrauma 2003; 20: 261-8.
39. Crocker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, et al. Inhibition of calpains prevents neuronal and behavioural deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 2003; 23: 4081-91.
40. Brorson JR, Marcuccilli CJ, Miller RJ. Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke 1995; 26: 1259-66, discussion 1267.
41. Corbacella E, Lanzoni I, Ding D, Previati M, Salvi R. Minocycline attenuates gentamicin induced hair cell loss in neonatal cochlear cultures. Hear Res 2004; 197: 11-8.
42. Nicotera TM, Ding D, McFadden SL, Salvemini D, Salvi R. Paraquat-induced hair cell damage and protection with the superoxide dismutase mimetic M40403. Audiol Neurootol 2004; 9: 353-62.
43. Chen ZF, Schottler F, Lee KS. Neuronal recovery after moderate hypoxia is improved by the calpain inhibitor MDL28170. Brain Res 1997; 769: 188-92.
44. Brana C, Benham, CD, Sundstrom LE. Calpain activation and inhibition in organotypic rat hippocampal slice cultures deprived of oxygen and glucose. Eur J Neurosci 1999; 11: 2375-84.
45. DeRosier DJ, Tilney LG. F-actin bundles are derivatives of microvilli: what does this tell us about how bundles might form? J Cell Biol 2000; 148: 1-6.
46. Loomis PA, Zheng L, Sekerkova G, Changyaleket, Mugnaini E, Bartles JR. Espin cross-links cause the elongation of microvillus-type parallel actin bundles in vivo. J Cell Biol 2003; 163, 1045-55.
47. Kitajiri S, Fukumoto K, Hata M, Sasaki H, Katsuno T, Nakagawa T, et al. Radixin deficiency causes deafness associated with progressive degeneration of cochlear stereocilia. J Cell Biol. 2004; 166: 559-70.
48. Pataky F, Pironkova R, Hudspeth AJ. Radixin is a constituent of stereocilia in hair cells. Proc Natl Acad Sci USA 2004; 101: 2601-6.
49. Shcherbina A, Bretscher A, Kenney DM, Remold-O'Donnell E. Moesin, the major ERM protein of lymphocytes and platelets, differs from ezrin in its insensitivity to calpain. FEBS Lett 1999; 443: 31-6.
50. Hoock TC, Newcomb PM, Herman IM. Beta actin and its mRNA are localized at the plasma membrane and the regions of moving cytoplasm during the cellular response to injury. J Cell Biol 1991; 112: 653-64.
51. Potter DA, Tirnauer JS, Janssen R, Croall DE, Hughes CN, Fiacco KA, et al. Calpain regulates actin remodelling during cell spreading. J Cell Biol 1998; 141: 647-62.
52. 2+ elevation, activation of TLCK-sensitive proteases, and cytochrome c release. Exp Cell Res 2001; 269: 202-13.
53. Liu N, Wang Y, Ashton-Rickardt PG. Serine protease inhibitor 2A inhibits caspase-independent cell death. FEBS Lett 2004; 569: 49-53.
54. Potter DA, Srirangam A, Fiacco KA, Brocks D, Hawes J, Herndon C, et al. Calpain regulates enterocyte brush border actin assembly and pathogenic Escherichia coli-mediated effacement. J Biol Chem 2003; 278: 30403-12.